APA (7th ed.) Citation

B, M., M, O., C, S., W, G., SB, K., A, B., . . . N, C. (2021). Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens. Breast cancer research and treatment, 188(2), 449. https://doi.org/10.1007/s10549-021-06217-4

Chicago Style (17th ed.) Citation

B, Moy, et al. "Neratinib + capecitabine Sustains Health-related Quality of Life in Patients with HER2-positive Metastatic Breast Cancer And ≥ 2 Prior HER2-directed Regimens." Breast Cancer Research and Treatment 188, no. 2 (2021): 449. https://doi.org/10.1007/s10549-021-06217-4.

MLA (9th ed.) Citation

B, Moy, et al. "Neratinib + capecitabine Sustains Health-related Quality of Life in Patients with HER2-positive Metastatic Breast Cancer And ≥ 2 Prior HER2-directed Regimens." Breast Cancer Research and Treatment, vol. 188, no. 2, 2021, p. 449, https://doi.org/10.1007/s10549-021-06217-4.